Peer-led education, real clinical protocols, and a network of practitioners adding regenerative tissue-allograft therapies to their practice — the right way. Founding access is practitioner-qualified and limited.
Not a course you finish and forget. A living network of protocols, training, and peers — plus a compliant supply path when you're ready.
Regenerative-medicine and orthobiologic training from a practicing clinician — mechanisms, patient selection, and integration into a real practice.
Documented clinical protocols for Wharton's Jelly, chorionic, and amniotic allograft integration — so you're not guessing on dosing, sequencing, or candidacy.
Practitioners at your level of clinical curiosity — a place to pressure-test cases and protocols instead of going it alone.
Dr. Funderlich-led workshops and case reviews, in person and online, as the community and curriculum grow.
When you're trained and ready, a straightforward route to Next Gen Lab biologics under a practitioner supply agreement.
Regulatory framing built in from day one — HCT/P status, sourcing transparency, and honest, evidence-informed language.
Not a vendor selling to physicians — a physician who co-founded the lab, teaches the protocols, and stands behind both.
Medical Director & Co-founder · Next Gen
A practicing chiropractic physician and regenerative-medicine educator who co-built the lab and the community — the training and the supply, from one clinician.
He co-founded the RCTM lab that produces Next Gen's Wharton's Jelly, chorionic, and amniotic tissue allografts, and is a current student in Johns Hopkins' Regenerative & Stem Cell Technologies program.
The result is a rare alignment for practitioners: the person setting the standard is the same one supplying the biologics and teaching the protocols.